AcoArt sICAS: DCB in the Treatment of Symptomatic Intracranial Atherosclerotic Stenosis

NACompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

June 4, 2021

Primary Completion Date

April 10, 2023

Study Completion Date

April 13, 2023

Conditions
Intracranial AtherosclerosisStroke
Interventions
DEVICE

drug coated balloon

paclitaxel coated balloon catheter for intracranial PTA treatment

DEVICE

stent system

The Intracranial Stent System comprises of a balloon expandable stent and a delivery catheter that features a rapid exchange catheter design with a semi-compliant balloon located at its distal end.The product, APOLLO™ stent system, has the indication of endovascular treatment for intracranial stenosis approved by NMPA.

Trial Locations (3)

Unknown

Beijing Tiantan Hospital, Beijing

Nanyang City Central Hospital, Nanyang

Shanxi Cardiovascular Hospital, Taiyuan

Sponsors
All Listed Sponsors
collaborator

Beijing Tiantan Hospital

OTHER

lead

Acotec Scientific Co., Ltd

INDUSTRY

NCT04631055 - AcoArt sICAS: DCB in the Treatment of Symptomatic Intracranial Atherosclerotic Stenosis | Biotech Hunter | Biotech Hunter